A simple methodology to assess modified proteins in blood during diabetes conditio
Not Applicable
- Conditions
- Health Condition 1: E082- Diabetes mellitus due to underlying condition with kidney complicationsHealth Condition 2: E088- Diabetes mellitus due to underlying condition with unspecified complications
- Registration Number
- CTRI/2022/01/039416
- Lead Sponsor
- Science and Engineering Research Board Department of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Control and Diabetic subjects with or without diabetic complications (neuropathy, nephropathy, atherosclerosis) willing to provide blood will be included in the study. For conducting our study, the blood samples of the participants will be collected as provided by the clinical collaborator from Department of Medicine, Kasturba Hospital, Manipal
Exclusion Criteria
Individuals with communicable diseases will be excluded from the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a new diagnostic tool of glycoalbumin measuremnt will be developedTimepoint: This is an observational study where the blood sample will be drawn from a patient (both, diabetic and non-diabetic) only once in the study. The respective parameters measured will be correlated with the patients clinical condition at the time of blood withdrawal.
- Secondary Outcome Measures
Name Time Method The study has transnational potentialTimepoint: 1 YEAR 10 MONTHS